COVID-19 and Pandemic Preparedness
Coronavirus

COVID-19 and Pandemic Preparedness

The COVID-19 pandemic gave rise to many questions about the specific impacts of the virus on people and health systems, as well as the world's ability to respond to future threats. Researchers and experts from across the world continue working rapidly to understand the interaction of co-morbidities and COVID-19, including liver disease. A broader conversation about the ways in which health system strengthening, including improved access to hepatitis care and treatment, can better prepare countries and communities to respond to many critical global needs to face pandemic threats. Below you'll find a collection of resources from the Coalition related to COVID-19 and pandemic preparedness.

Report: Sharing Investments in Hepatitis Elimination and Pandemic Preparedness

The Coalition has published a report establishing that many critical global needs for building resilient health systems to face pandemic threats can be met by expanded efforts to eliminate viral hepatitis. The report, titled “Building Resilient Health Systems: Sharing Investments in Hepatitis Elimination and Pandemic Preparedness” provides an overview of how investments in achieving hepatitis elimination and preparing for the next pandemic are mutually reinforcing.

Synthesis on COVID-19 and liver disease

Researchers and experts from across the world have been working rapidly to understand theinteraction of co-morbidities and COVID-19, including liver disease. In this synthesis published in April, Dr. Ward summarized the current status of the evidence on COVID-19 and liver disease.

Clinical Liver Disease series

The Coalition worked with Clinical Liver Disease, a journal of AASLD, to publish an 8 article series related to COVID-19 and liver disease.

Dr. Ward, Director of the Coalition, co-authored two of these articles:

Read the full series here.

Other resources

AASLD EXPERT PANEL CONSENSUS STATEMENT: VACCINES TO PREVENT COVID-19 INFECTION IN PATIENTS WITH LIVER DISEASE

ANALYZING AND USING ROUTINE DATA TO MONITOR THE EFFECTS OF COVID-19 ON ESSENTIAL HEALTH SERVICES: PRACTICAL GUIDE FOR NATIONAL AND SUBNATIONAL DECISION-MAKERS

AASLD EXPERT PANEL CONSENSUS STATEMENT: VACCINES TO PREVENT COVID-19 IN PATIENTS WITH LIVER DISEASE August 2021

SUPPLEMENTAL MATERIALS

CLINICAL BEST PRACTICE ADVICE FOR HEPATOLOGY AND LIVER TRANSPLANT PROVIDERS DURING THE COVID-19 PANDEMIC: AASLD EXPERT PANEL CONSENSUS STATEMENT

EASL POSITION PAPER ON THE USE OF COVID-19 VACCINES IN PATIENTS WITH CHRONIC LIVER DISEASES, HEPATOBILIARY CANCER AND LIVER TRANSPLANT RECIPIENTS

OUTCOMES FOLLOWING SARS-CoV-2 INFECTION IN PATIENTS WITH CHRONIC LIVER DISEASE: AN INTERNATIONAL REGISTRY STUDY

WGO GUIDANCE FOR THE CARE OF PATIENTS WITH COVID-19 and LIVER DISEASE 

Relevant links EASL: https://easl.eu/covid-19-and-the-liver/

AASLD: https://www.aasld.org/about-aasld/covid-19-and-liver

Page last updated: 25 January 2024